Reduction of LDL receptor (LDLR) expression and LDL uptake, by either enhancing receptor degradation11, or genetic manipulation reduced tumor growth in pre-clinical pancreatic and breast cancer models5,10, providing evidence for the association between lipoprotein uptake and the promotion of tumor progression in some cancers. The gene discussed is LDLR; the disease is cancer.